| Autor: |
Vila JJ; Endoscopy Unit. Gastroenterology Department, Hospital Universitario de Navarra, España., Jusué Irurita V; Endoscopy Unit. Gastroenterology Department, Hospital Universitario de Navarra., Rullán Iriarte M; Endoscopy Unit. Gastroenterology Department, Hospital Universitario de Navarra. |
| Jazyk: |
angličtina |
| Zdroj: |
Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2024 Apr; Vol. 116 (4), pp. 182-185. |
| DOI: |
10.17235/reed.2023.10029/2023 |
| Abstrakt: |
Endoscopic retrograde cholangiopancreatography (ERCP) has been established as the first line therapy for the resolution of biliary and pancreatic diseases. The main disadvantage of the procedure is the rate of adverse events, around 10%1. So, despite being a minimally invasive procedure, ERCP has a non-negligible rate of adverse effects (AEs) and secondary mortality. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
